Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.
Patheon has closed the acquisition of IRIX Pharmaceuticals, a company that specialises in making difficult to manufacture active pharmaceutical ingredients (API) for drugs from early and late development, through to commercial launch.
With this acquisition, Patheon will establish a North American presence for comprehensive API development and manufacturing to address customers’ most challenging needs for drugs in all development phases.
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
